Clinical Trial Update: Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update investigates the relationship between changes in HbA1c, urinary glucose excretion, and other factors in patients treated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Suglat (ipragliflozin)

Snippet

Sponsor: Asan Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED